Asset
RASEGLURANT
Addex Therapeutics Ltd American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00820105 | phase2 | terminated | 2008-12-01 | 2010-01-01 | Addex Pharma S.A. | ADX10059 Migraine Prevention Study |
| NCT00820079 | phase2 | completed | 2008-12-01 | 2009-10-01 | Addex Pharma S.A. | ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD) |
| NCT00810485 | phase2 | completed | 2008-12-01 | 2009-12-01 | Addex Pharma S.A. | ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) |
FDA applications (0)
This company has no applications containing this asset.